DNA Miracles, Ltd. – Trademark Portfolio

Entity Type: 03

DNA Miracles, Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DNA and DNA MIRACLES. The owner is based in Greensboro, NC.

1302 Pleasant Ridge Road

Greensboro, NC 27409

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DNA Miracles, Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (5 filings)

Clothing, footwear, headgear

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (4 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does DNA Miracles, Ltd. have?

DNA Miracles, Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned, 1 cancelled.

What trademark classes does DNA Miracles, Ltd. file in?

DNA Miracles, Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 25 covers clothing, footwear, headgear.

What are DNA Miracles, Ltd.'s most well-known trademarks?

DNA Miracles, Ltd.'s registered trademark portfolio includes well-known marks such as DNA and DNA MIRACLES. These are among 2 currently registered trademarks in the portfolio.

What is DNA Miracles, Ltd.'s trademark registration success rate?

DNA Miracles, Ltd. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.